EBM Technologies Incorporated

TWO:8409 Taiwan Health Information Services
Market Cap
$19.54 Million
NT$646.40 Million TWD
Market Cap Rank
#28045 Global
#1769 in Taiwan
Share Price
NT$20.20
Change (1 day)
+0.50%
52-Week Range
NT$20.10 - NT$25.35
All Time High
NT$25.35
About

EBM Technologies Incorporated engages in the development and marketing of software and integrity solutions to the health sector in Taiwan and internationally. The company offers Enterprise PACS (picture archiving and communication systems) solutions, including SoliPACS that unites various products of the radiology, mammography, and dental fields; SoliPACS Gateway, a DICOM gateway; SoliPACS Server… Read more

EBM Technologies Incorporated (8409) - Net Assets

Latest net assets as of June 2025: NT$261.66 Million TWD

Based on the latest financial reports, EBM Technologies Incorporated (8409) has net assets worth NT$261.66 Million TWD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$438.83 Million) and total liabilities (NT$177.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets NT$261.66 Million
% of Total Assets 59.63%
Annual Growth Rate 0.38%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 3.19

EBM Technologies Incorporated - Net Assets Trend (2021–2024)

This chart illustrates how EBM Technologies Incorporated's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for EBM Technologies Incorporated (2021–2024)

The table below shows the annual net assets of EBM Technologies Incorporated from 2021 to 2024.

Year Net Assets Change
2024-12-31 NT$313.45 Million +2.22%
2023-12-31 NT$306.66 Million -4.05%
2022-12-31 NT$319.60 Million +3.13%
2021-12-31 NT$309.88 Million --

Equity Component Analysis

This analysis shows how different components contribute to EBM Technologies Incorporated's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 417800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components NT$384.97 Million 122.82%
Total Equity NT$313.45 Million 100.00%

EBM Technologies Incorporated Competitors by Market Cap

The table below lists competitors of EBM Technologies Incorporated ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in EBM Technologies Incorporated's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 306,657,000 to 313,453,000, a change of 6,796,000 (2.2%).
  • Net income of 2,140,000 contributed positively to equity growth.
  • Other factors increased equity by 4,656,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income NT$2.14 Million +0.68%
Other Changes NT$4.66 Million +1.49%
Total Change NT$- 2.22%

Book Value vs Market Value Analysis

This analysis compares EBM Technologies Incorporated's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.06x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-12-31 NT$9.68 NT$20.20 x
2022-12-31 NT$9.99 NT$20.20 x
2023-12-31 NT$9.58 NT$20.20 x
2024-12-31 NT$9.80 NT$20.20 x

Capital Efficiency Dashboard

This dashboard shows how efficiently EBM Technologies Incorporated utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.68%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.76%
  • • Asset Turnover: 0.50x
  • • Equity Multiplier: 1.79x
  • Recent ROE (0.68%) is above the historical average (-2.42%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 -7.05% -11.21% 0.32x 1.94x NT$-52.85 Million
2022 1.25% 1.04% 0.82x 1.47x NT$-27.96 Million
2023 -4.57% -6.80% 0.42x 1.59x NT$-44.67 Million
2024 0.68% 0.76% 0.50x 1.79x NT$-29.21 Million

Industry Comparison

This section compares EBM Technologies Incorporated's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $1,264,654,500
  • Average return on equity (ROE) among peers: 9.94%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
EBM Technologies Incorporated (8409) NT$261.66 Million -7.05% 0.68x $11.16 Million
Onyx Healthcare Inc. (6569) $1.02 Billion 23.47% 0.35x $35.87 Million
Ever Fortune.AI Co. Ltd. (6841) $1.51 Billion -3.59% 0.03x $109.81 Million